SRG

Seritage Growth Properties 2025 Annual Report (10-K) Summary

Business Context and Reporting Period

Company: Seritage Growth Properties (NYSE: SRG)
Reporting Period: Fiscal year ended December 31, 2025
Business Model: Seritage is a taxable C Corporation (formerly a REIT) executing a shareholder-approved "Plan of Sale" to liquidate its real estate portfolio and distribute proceeds. The company owns, develops, and sells retail and mixed-use properties.
Portfolio Status: As of December 31, 2025, the portfolio consists of 10 properties (5 consolidated, 5 unconsolidated) totaling approximately 0.8 million square feet of Gross Leasable Area (GLA) and 156 acres of land.

Key Financial Metrics

Material Changes vs. Prior Period

• Asset Sales: The company sold five consolidated properties in 2025, generating $222.6 million in gross proceeds, compared to 13 properties sold in 2024 for $163.5 million. This resulted in a net gain on sale of real estate of $20.3 million in 2025 versus $10.7 million in 2024.
• Debt Reduction: Significant deleveraging occurred with $190.0 million in principal prepayments on the Term Loan Facility, reducing the outstanding balance from $240.0 million to $50.0 million.
• Impairment Charges: Impairment of real estate assets decreased significantly to $18.8 million in 2025 from $87.5 million in 2024. The 2024 charge was largely driven by the Aventura, FL development property.
• Operating Expenses: General and administrative expenses increased by $1.9 million to $31.9 million, primarily due to $6.7 million in severance expenses.
• Unconsolidated Entities: Equity in loss of unconsolidated entities increased to $13.2 million (from $3.2 million) due to $8.5 million in other-than-temporary impairment losses and a $7.1 million share of impairment charges from a joint venture.

Guidance, Outlook, Risks, and Contingencies

• Going Concern: Management has concluded that its plans do not alleviate substantial doubt about the company's ability to continue as a going concern. Anticipated proceeds from assets under contract and existing cash are insufficient to fund obligations, specifically the Term Loan Facility maturing on July 31, 2026.
• Plan of Sale: The company remains focused on executing the Plan of Sale. One consolidated property is under contract to sell for $11.0 million as of March 31, 2026. Proceeds from asset sales are the primary source of liquidity.
• Debt Maturity: The Term Loan Facility maturity was extended to July 31, 2026, upon payment of a $4.0 million extension fee. The company has not met the rental income thresholds required to access the $400 million Incremental Funding Facility.
• Internal Controls: The company identified material weaknesses in internal control over financial reporting related to the review of the general ledger and segregation of duties over journal entries. These remain unremediated as of December 31, 2025.
• Litigation: The company is defending against a securities class action lawsuit and three derivative lawsuits alleging violations of federal securities laws and breach of fiduciary duty regarding internal controls and asset valuations. No amounts have been accrued for these matters.
• Dividends: No dividends were declared on Class A common shares in 2025. Dividends on Series A Preferred Shares ($0.4375 per quarter) continue to be declared and paid.

Key Facts for Investor Verification

• Liquidity Risk: Verify the company's ability to refinance or repay the $50.0 million Term Loan Facility maturing in July 2026, given the "substantial doubt" going concern disclosure.
• Asset Valuation: Confirm the fair value and saleability of the remaining 10 properties, particularly the unconsolidated entities which recently recorded significant impairment losses.
• Internal Controls: Monitor the remediation progress of the material weaknesses in internal controls, which could impact the reliability of future financial reporting.
• Litigation Exposure: Track the status of the securities class action and derivative lawsuits, as an unfavorable outcome could result in significant damages or governance changes.
• Plan of Sale Execution: Assess the timeline and pricing of remaining asset sales, as delays or lower-than-expected proceeds will directly impact shareholder distributions.